Researchers

(Abdiel, Rava, Tallula, Tristan)
Abdiel
Rava
Talulla
Tristan

Mentors

(Ms. Fany, Ms. Sari, Ms. Risna)

How We Organize Ourselves

“An inquiry into the interconnectedness of human-made systems and communities; the structure and function of organizations; societal decision-making; economic activities and their impact on humankind and the environment

Central Idea

Collaboration among government and citizens in distributing COVID-19 vaccine.

Lines of Inquiry

1. The function of the government in the process of distributing the COVID-19 vaccine. (Function)

2. The process of distributing the COVID-19 vaccine. (Perspective)

3. The responsibility of the government and citizens in distributing the COVID-19 vaccine. (Responsibility)

Learning Outcomes

1. Recognize the elements of major political systems

2. Examine how the roles and rights of a person in a particular society directly affect their responsibilities

3. Explore a range of systems (local, regional, national and international) and the impact they have on individuals, groups, and society.

Indonesia reports new daily COVID-19 record, total cases top 800,000

 

Indonesia reported on Friday a record daily number of new COVID-19 cases for the third successive day with 10,617 infections, bringing the total to over 800,000, data from the country’s COVID-19 tadk force showed. The Southeast Asia biggest country also reported 233 new COVID-19 deaths, taking that total to 23,753 More than 87.42 million people have been reported to be infected by the novel coronavirus
globally and 1,888,982 have died, according to a Reuters tally. Infections have been reported in more than 210 countries and territories since the first cases were identified in China in December 2019.

 

 

 

 

 

 

 

Resource: Jakarta Post, (2021, Jan 8). Indonesia reports new daily COVID-19 record, total cases top 800.000. Retrieved from: https://www.thejakartapost.com/news/2021/01/08/indonesia-reports-new-daily-covid-19-record-total-cases-top-800000.html

 

COVID-19 Vaccine


The world is in the midst of a COVID-19 pandemic. As WHO and partners work together on the response — tracking the pandemic, advising on critical interventions, distributing vital medical supplies to those in need— they are racing to develop and deploy safe and effective vaccines. 

 

Vaccines save millions of lives each year. Vaccines work by training and preparing the body’s natural defences — the immune system— to recognize and fight off the viruses and bacteria they target. After vaccination, if the body is later exposed to those disease-causing germs, the body is immediately ready to destroy them, preventing illness.

 

As of 18 February 2021, at least seven different vaccines across three platforms have been rolled out in countries. Vulnerable populations in all countries are the highest priority for vaccination.

 

At the same time, more than 200 additional vaccine candidates are in development, of which more than 60 are in clinical development. COVAX is part of the ACT Accelerator, which WHO launched with partners in 2020. COVAXthe vaccines pillar of ACT Accelerator, convened by CEPI, Gavi and WHO, aims to end the acute phase of the COVID-19 pandemic by:

 

·        speeding up the development of safe and effective vaccines against COVID-19;

·        supporting the building of manufacturing capabilities; and

·        working with governments and manufacturers to ensure fair and equitable allocation of the vaccines for all countries – the only global initiative to do so.

 

Vaccines are a critical new tool in the battle against COVID-19 and it is hugely encouraging to see so many vaccines proving successful and going into development. Working as quickly as they can, scientists from across the world are collaborating and innovating to bring us tests, treatments and vaccines that will collectively save lives and end this pandemic.  

  

Safe and effective vaccines will be a game-changer: but for the foreseeable future we must continue wearing masks, physically distancing and avoiding crowds. Being vaccinated does not mean that we can throw caution to the wind and put ourselves and others at risk, particularly because it is still not clear the degree to which the vaccines can protect not only against disease but also against infection and transmission.

 

Resource: WHO (2021). COVID-19 vaccine. Retrieved from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines.

First batch of COVID-19 vaccine lands in Indonesia


The first consignment of the COVID-19 vaccine produced by China’s Sinovac Biotech has arrived in Indonesia, but the government still has to wait for emergency use authorization before starting the vaccination program, President Joko “Jokowi” Widodo has said. A total of 1.2 million doses of the vaccine are now stored in a warehouse of state-owned pharmaceutical company PT Bio Farma in Bandung, West Java, having landed at Soekarno-Hatta International Airport on Sunday evening. It remains unclear when the government will roll out the vaccine for public use as the government is still waiting for the emergency approval from the Indonesian Food and Drug Monitoring Agency (BPOM), while also ramping up the infrastructure required.

 

A total of 1.2 million doses of the vaccine are now stored in a warehouse of state-owned pharmaceutical company PT Bio Farma in Bandung, West Java, having landed at Soekarno-Hatta International Airport on Sunday evening. It remains unclear when the government will roll out the vaccine for public use as the government is still waiting for the emergency approval from the Indonesian Food and Drug Monitoring Agency (BPOM), while also ramping up the infrastructure required.

 

“We are very grateful, Alhamdulillah, the vaccine is available, which means that we can immediately prevent the spread of the COVID-19 outbreak, but in order to start vaccination, there are still some steps [needed] from the BPOM,” Jokowi said on Sunday evening. The government is expecting another arrival of 1.8 million doses of the ready-to-administer Sinovac vaccine early next month. Indonesia also expects to receive 15 million doses of bulk vaccines, an aqueous form of the purified antigens, this year and 30 million doses more next year, according to Jokowi.

The bulk vaccines will be used by state-owned pharmaceutical company PT Bio Farma to manufacture ready-to-use vaccines. In total, Indonesia has ordered around 143 million doses from Sinovac in various forms, from the ready-to-administer doses to the bulk vaccines.

 

The Sinovac vaccine is one of several COVID-19 candidate vaccines in final-stage testing globally. Sinovac has said it is confident about the safety of the potential vaccine, which has been tested in several countries including in Indonesia since August.  An interim report comprising evidence of efficacy, immunogenicity and safety will be delivered to the BPOM in early January to obtain emergency use authorization. Prior to the vaccine’s arrival, the BPOM said it would not authorize the emergency use of a Sinovac candidate vaccine in December because of a lack of data on its effectiveness, rebuking the government’s target to have the approval this month. BPOM head Penny Kusumastuti Lukito estimated that approval could come in the third or fourth week of January 2021.

 

Jokowi said that all steps must be taken properly in order to ensure public health, safety and vaccine effectiveness. “Scientific considerations, clinical trial results will determine when vaccination can begin,” he added. The President also said it was also important to prepare a vaccine distribution system to all regions in Indonesia, as well as supporting equipment, human resources and vaccination management. “We know that we have made some preparations since a few months ago through simulations in several provinces, so everything has to be ready when we start a vaccination program,” he said. Health Minister Terawan Agus Putranto said the government would prioritize health workers for the vaccines that had just arrived in Indonesia.

 

Resource: Jakarta Post (2020, December 7). First batch of COVID-19 vaccine lands in Indonesia – National – The Jakarta Post. Retrieved from: https://www.thejakartapost.com/news/2020/12/07/first-batch-of-covid-19-vaccine-lands-in-indonesia.html.

 

Survey (Identification of the Problems)

We conducted a survey to know the problems arise in the citizen during this pandemic. The focus is to know what causes the spreading of the COVID-19 virus which still increasing and how to prevent/reduce it. There are 202 respondents in this survey. The respondents of this survey are 61.4 % of female and 38.6% of the respondents are male. They are mostly in the age of 23-59 years old (94.6%) and the rest are teenagers and elderly. Moreover, half of the respondents work as staff (53.5%) and the rest of them are students, parents, and 2 doctors. The result of the survey is listed below.

Based on the results of a survey regarding the government’s efforts to break the chain of the spread of the Covid 19 virus, out of 202 correspondents, 12.9% said the government had implemented 3M regulations. 4% of the government implemented 3T, 9.9% made PSBB regulations, 11.4% provided vaccines and 79.2% said everything had been implemented. This means that the public understands that the government has worked hard to break the chain of spreading the Covid 19 virus.

The data said that 58.9% of the people adhere to health protocols such as wearing masks, washing hands, and maintaining distance. People who still break the protocol are 41.1% of the respondents. This means that public awareness of the importance of health protocols is still low.

The data said that 61% of the citizens (123 respondents) were still breaking the rules of health protocols, which is not maintaining their distance. Moreover, 21.1% of the respondents are not wearing masks properly and 17.9% are not washing their hands appropriately. This means that there are still many people who neglect to keep following the rules of health protocols.

The data said that there are still many people who do not routinely do swab. The data said that 202 correspondents (63.9%) do not routinely do swab and only 30.7% do a routine swab.

The data said that the people are sufficiently obedient to this social restriction regulation as evidenced by a high percentage of 65.3%. However, 34.7% are not yet obedient to the rules. We can concluded that some of the citizens are still not following the rules created by government.

What have we already known about the topic?

We knew that COVID-19 has already existed in Indonesia for about almost a year in January 2021. The cases of COVID-19 keep increasing even though government and citizen have tried several ways to stop the virus such as following health protocol, creating rules of PSBB, limiting the activities of citizen in public places, closing the public places, etc.

 

What would we like to know more about?

We want to know more about COVID-19 vaccine because it is a new solution that government gives to citizen in order to prevent the spreading of COVID-19 virus.

1.   What is COVID-19 vaccine?

2.   How does it work in our body?

3.   Is it halal/haram?

4.   How does the vaccine help to prevent the spreading of COVID-19
virus?

5.   What is the function of government in the process of distributing
the COVID-19 vaccine?

6.   How does the government distribute the COVID-19 vaccine?

7.   What are the difficulties in distributing the COVID-19 vaccine?

8.   How can government ensure that all citizens get the vaccine?

9.   What kind of things that citizen can do to help the government
about the vaccine?

10.   How does the citizen get the vaccine?

 

Al Qur’an Quotation

 

“Sesungguhnya Allah menyuruh kamu menyampaikan amanat kepada yang berhak menerimanya, dan (menyuruh kamu) apabila menetapkan hukum di antara manusia supaya kamu menetapkan dengan adil. … Sesungguhnya Allah adalah Maha mendengar lagi Maha melihat.” (An-Nisa Ayat: 58)

In the second step, students formulated their own Central Idea and Lines of Inquiry using their previous inquiry questions. Moreover, students also planned their time in conducting this PYP Exhibition. Students set the time frame to help them maintain well-structured progress every week. After that, they also discussed their success criterias of this PYP Exhibition.

Success Criterias

Learning Continuum

GRADE 1

We have learned about healthy lifestyle. We learned that the choices we make affect our health and well being. We need certain resources for energy and growth. We also learned to be aware of the role of major food group in human development. All the learning focus on achieving a balanced lifestyle.

healthy-lifestyle

GRADE 2

In Grade 2, we have learned about organization. We learned that organization is created to solve problems and support human activities. Moreover, we also learned that people have different responsibilities in organization. We also learned to work in a group to establish a shared vision and purpose for the class organization.

GRADE 3

In Grade 3, we learned about human body system. The learning purpose is to know how effective interactions inside human body system contribute people health and survival. We learned how to take care of our body responsibly with regards to our health.

Play Video

Furthermore, to get a deeper understanding about the topic, students were asked to research about COVID-19 and vaccine. We discussed what they have learned from the books/articles during mentor meeting on Zoom.

Literature Research

Reflection

Abdiel
Rava

In the first meeting of this step, we explored the SGD that related to our research topic. We agreed that our SDG is about …..

After that, in the next meeting we discussed about how to collect the data for our research. We agree to find the sources about COVID-19 Vaccine from government and medical personnel. To get data from the government, we interviewed the chief of SATGAS COVID-19 representative from NU, Bapak dr. M. Makki Zamzami. Moreover, to get data from medical personnel, we interviewed two doctors who work in a hospital, dr. Ahmad Faizal M.Sc, Sp.PD. and dr. Reno Ashaf.

Interviewing dr. Ahmad Faizal M.Sc, Sp.PD. (Medical Personnel)

Reflection

Interviewing dr. M. Makki Zamzami (SATGAS COVID-19)

Reflection

Interviewing dr. Reno Ashaf (Medical Personnel)

Reflection

After we interviewed the experts on this topic, we discussed the interview results. The data showed that there are steps to get the vaccine. Moreover, there is also a change in the requirements for vaccine recipients. The previous info, the vaccine can be given for those who in the age of 18-59 years old, however, the new requirement stated that it can be given to citizens start from 18 years old above.

The guest speakers also said that there is the infrastructure required to distribute the vaccine to the citizen. The vaccine should be kept at a cool temperature which requires proper health facilities to be a place for vaccination. 

Finally, we decided to survey by using an online questionnaire to the citizen. This experiment aims to know how well the citizen knows about the vaccine and their willingness to get the vaccine.

Survey to the Community

We conducted a survey to know how well the citizens know about the COVID-19 vaccine as one of the ways to reduce the spreading of the virus.  There are 202 respondents in this survey. The respondents of this survey are 61.4 % of female and 38.6% of the respondents are male. They are mostly in the age of 23-59 years old (94.6%) and the rest are teenagers and elderly. Moreover, half of the respondents work as staff (53.5%) and the rest of them are students, parents, and 2 doctors. The result of the survey is listed below.

Based on the data, we can conclude that the citizens know that the government has provided the COVID-19 vaccine as a way to reduce the spread of the COVID-19 virus.
Based on the data, the public has already known that certain age ranges can receive the COVID-19 vaccine.
Based on the data, 80.7% of the respondents think that the vaccine recipients are 18-59 years old. Furthermore, 12,8 % of the respondents think that all ages can receive the vaccine. Moreover, the rest of the respondents think that only 18 years above that can receive the vaccine.
The data shows that 75,2% of respondents know that there are several steps that will be passed before receiving a vaccine injection. However, 24.8% of the respondents did not know it.
The data says that almost 93% of correspondents agree that vaccine is not the medicine that can cure COVID-19 patients. However, 7.4% of the respondents think otherwise.
The data says that only 3% (2 persons) of the respondents have received the vaccine injection. However, the rest 97% of the respondents have not received the vaccine.
Based on this data, 19% of respondents stated that they are not willing to be injected with the COVID-19 vaccine. The data of the survey said that some of the respondents do not want to be injected because they have not trusted the vaccine yet. It is due to a lot of misinformation about the vaccine in the media. 

 

On the other hand, 80.9% of the respondents are willing to get the vaccine but they do not know how to get the vaccine because it is still limited.

Social Experiments

After interviewing and conducting survey, we can conclude from the data that some of the citizens still do not get the sufficient information about the vaccine. This problem is one of the obstacles that make distribution of the COVID-19 vaccine has not run effectively. Therefore, we conducted a social experiment to know how well the citizens get the information about vaccine COVID-19 and how we can help the government to support the distribution of the vaccine. There are 101 respondents in this experiment that includes 56.4% of female and 43.6% of male respondents. The result of the social experiments is listed below.

Based on this data, 26.7% of respondents are 18-22 years old. Then, 54.5% of the respondents are 23-59 years old and the rest are elder (18.8%).
Based on this data, there are 101 respondents in this experiment that includes 56.4% of female and 43.6% of male respondents.
The data concluded that 78.2% of the respondents have not received the COVID-19 vaccine injection. However, the rest of the respondents (21.8%) have received it. 
Based on this data, we can conclude that 78.5% of the respondents have not registered the COVID-19 vaccine injection yet. However, 21.5% of them has registered but they are still waiting for further information.
Based on this data, those who have not get the vaccine are still confuse how to get the vaccine. They said that they do not understand how to register for the vaccine.
The respondents who have got the vaccine (21.8%) said that they mostly got the vaccine from the place they work such as office, Kementrian, Puskesmas, School.
Based on this data, the respondents who have got the vaccine (21.8%) said that they got the information mostly from the place they work.
The data concluded that the respondents (77.2%) are still think the information about COVID-19 vaccine that government gives has not enough. It is still not clear.
The respondents mostly suggest the government to give the information from social media, especially Instagram and WhatsApp. Moreover, some of them also suggest to use TV, poster, RT/RW, and parents.

Reflection

Sharing Information on Instagram

Ayo Vaksin COVID-19 Campaign

Poster

After we conducted our exhibition and did the action, we shared our exhibition journey to our Head of School (Ibu Uchu), IB principal (Mr. Arie), PYP coordinator (Mr. Ryan), parents and teachers. They asked us some questions about our exhibition and alhamdulillah we were able to answer it well.